These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8748608)

  • 21. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia.
    Dexter DT; Sian J; Jenner P; Marsden CD
    Adv Neurol; 1993; 60():273-81. PubMed ID: 8420143
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of the serotonin 5-HT(7) receptor antagonist SB-269970 on the inhibition of dopamine neuronal firing induced by amphetamine.
    Mnie-Filali O; Dahan L; Zimmer L; Haddjeri N
    Eur J Pharmacol; 2007 Sep; 570(1-3):72-6. PubMed ID: 17586491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consequences of partial and severe dopaminergic lesion on basal ganglia oscillatory activity and akinesia.
    Tseng KY; Kargieman L; Gacio S; Riquelme LA; Murer MG
    Eur J Neurosci; 2005 Nov; 22(10):2579-86. PubMed ID: 16307600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development.
    Janhunen S; Ahtee L
    Neurosci Biobehav Rev; 2007; 31(3):287-314. PubMed ID: 17141870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional neuroanatomy of the basal ganglia in Parkinson's disease.
    Wichmann T; DeLong MR
    Adv Neurol; 2003; 91():9-18. PubMed ID: 12442660
    [No Abstract]   [Full Text] [Related]  

  • 26. Physiological properties of zebra finch ventral tegmental area and substantia nigra pars compacta neurons.
    Gale SD; Perkel DJ
    J Neurophysiol; 2006 Nov; 96(5):2295-306. PubMed ID: 16870835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel in vivo electrophysiological assay for the effects of cocaine and putative "cocaine antagonists" on dopamine transporter activity of substantia nigra and ventral tegmental area dopamine neurons.
    Hinerth MA; Collins HA; Baniecki M; Hanson RN; Waszczak BL
    Synapse; 2000 Dec; 38(3):305-12. PubMed ID: 11020233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Origin of chorea-ballism and multisystem degeneration: pathophysiological implications.
    Obeso JA; Luquin MR; Herrero MT; Guridi J
    Mov Disord; 1993; 8(1):123-4. PubMed ID: 8419800
    [No Abstract]   [Full Text] [Related]  

  • 29. Death in the substantia nigra: a motor tragedy.
    Esposito E; Di Matteo V; Di Giovanni G
    Expert Rev Neurother; 2007 Jun; 7(6):677-97. PubMed ID: 17563251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signalling through phospholipase C beta 4 is not essential for midbrain dopaminergic neuron survival.
    Smits SM; van der Nobelen S; Hornman KJ; von Oerthel L; Burbach JP; Smidt MP
    Neuroscience; 2005; 136(1):171-9. PubMed ID: 16198487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
    Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE
    Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feeding signals and drugs meet in the midbrain.
    Simerly R
    Nat Med; 2006 Nov; 12(11):1244-6. PubMed ID: 17088890
    [No Abstract]   [Full Text] [Related]  

  • 33. Midbrain muscarinic receptor mechanisms underlying regulation of mesoaccumbens and nigrostriatal dopaminergic transmission in the rat.
    Miller AD; Blaha CD
    Eur J Neurosci; 2005 Apr; 21(7):1837-46. PubMed ID: 15869479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and cellular alterations in the Pitx3-deficient midbrain dopaminergic system.
    Smits SM; Mathon DS; Burbach JP; Ramakers GM; Smidt MP
    Mol Cell Neurosci; 2005 Nov; 30(3):352-63. PubMed ID: 16140547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
    Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
    Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not elicit long-lasting increases in cyclooxygenase-2 expression in dopaminergic neurons of monkeys.
    Vázquez-Claverie M; Garrido-Gil P; San Sebastián W; Belzunegui S; Izal-Azcárate A; López B; Marcilla I; Luquin MR
    J Neuropathol Exp Neurol; 2009 Jan; 68(1):26-36. PubMed ID: 19104449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphetamine induces dendritic growth in ventral tegmental area dopaminergic neurons in vivo via basic fibroblast growth factor.
    Mueller D; Chapman CA; Stewart J
    Neuroscience; 2006 Feb; 137(3):727-35. PubMed ID: 16338078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histological changes of the dopaminergic nigrostriatal system in aging.
    Stark AK; Pakkenberg B
    Cell Tissue Res; 2004 Oct; 318(1):81-92. PubMed ID: 15365813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Implications of the strio-nigro-striated ring in extrapyramidal function].
    Poirier LJ
    Mars Med; 1971; 108(3):177-82. PubMed ID: 4995915
    [No Abstract]   [Full Text] [Related]  

  • 40. Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene.
    Castillo SO; Baffi JS; Palkovits M; Goldstein DS; Kopin IJ; Witta J; Magnuson MA; Nikodem VM
    Mol Cell Neurosci; 1998 May; 11(1-2):36-46. PubMed ID: 9608532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.